2018
To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in (…)
Consulter 
2018
In Alzheimer’s disease (AD), pathological changes may arise up to 20 years before the onset of dementia. This pre-dementia window provides (…)
Consulter
2019
Alzheimer’s disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With (…)
Consulter
2019
Amnestic mild cognitive impairment (aMCI) is a clinical entity with various potential etiologies including but not limited to Alzheimer’s disease. (…)
Consulter
2019
Sleep disturbances are increasingly recognized as a risk factor for Alzheimer’s disease. However, no study has assessed the relationships between (…)
Consulter
2019
There is increasing evidence that meditation-based training promotes healthy ageing across many dimensions. This review summarizes the existing knowledge on (…)
Consulter
